ODONATE THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On December 10, 2020, John Lemkey resigned as Chief Operating Officer of Odonate Therapeutics, Inc. (the "Company"). Mr. Lemkey's resignation was not the result of any disagreement with the Company. Mr. Lemkey's responsibilities have been assumed by Michael Hearne, Chief Financial Officer, and Ryan Cole, Vice President of Operations.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits



 Exhibit
   No.                                   Description

104         Cover Page Interactive Data File (embedded within the Inline XBRL
            document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses